{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T11:03:15Z","timestamp":1780743795549,"version":"3.54.1"},"reference-count":12,"publisher":"Baskent University","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.6002\/ect.2020.0385","type":"journal-issue","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T07:04:58Z","timestamp":1614927898000},"source":"Crossref","is-referenced-by-count":3,"title":[],"prefix":"10.6002","volume":"21","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Smith JM, Weaver T, Skeans MA, et al. OPTN\/SRTR 2018 Annual Data Report: Intestine. Am J Transplant. 2020;20 Suppl s1:300-339. doi:10.1111\/ajt.15675","DOI":"10.1111\/ajt.15675"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Celik N, Mazariegos GV, Soltys K, et al. Pediatric intestinal transplantation. Gastroenterol Clin North Am. 2018;47(2):355-368. doi:10.1016\/j.gtc.2018.01.007","DOI":"10.1016\/j.gtc.2018.01.007"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Petit LM, Rabant M, Canioni D, et al. Impacts of donor-specific anti-HLA antibodies and antibody-mediated rejection on outcomes after intestinal transplantation in children. Pediatr Transplant. 2017;21(2). doi:10.1111\/petr.12847","DOI":"10.1111\/petr.12847"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Sharma RR, Marwaha N. Leukoreduced blood components: Advantages and strategies for its implementation in developing countries. Asian J Transfus Sci. 2010;4(1):3-8. doi:10.4103\/0973-6247.59384","DOI":"10.4103\/0973-6247.59384"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Gavva C, Barroso J, Gernsheimer T, Metcalf RA, Warner P, Pagano MB. Response to random apheresis platelets versus HLA-selected platelets versus pooled platelets in HLA-sensitized patients. Transfusion. 2019;59(7):2276-2281. doi:10.1111\/trf.15333","DOI":"10.1111\/trf.15333"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Gan X, Xing D, Su G, et al. Propofol attenuates small intestinal ischemia reperfusion injury through inhibiting NADPH oxidase mediated mast cell activation. Oxid Med Cell Longev. 2015;2015:167014. doi:10.1155\/2015\/167014","DOI":"10.1155\/2015\/167014"},{"key":"ref6","unstructured":"7. Wu MB, Ma B, Zhang TX, Zhao K, Cui SM, He SC. Propofol improves intestinal ischemia-reperfusion injury in rats through NF-kappaB pathway. Eur Rev Med Pharmacol Sci. 2020;24(11):6463-6469. doi:10.26355\/eurrev_202006_21545"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Li Q, Cui S, Jing G, Ding H, Xia Z, He X. The role of PI3K\/Akt signal pathway in the protective effects of propofol on intestinal and lung injury induced by intestinal ischemia\/reperfusion1. Acta Cir Bras. 2019;34(1):e20190010000005. doi:10.1590\/s0102-865020190010000005","DOI":"10.1590\/s0102-865020190010000005"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Shen JT, Li YS, Xia ZQ, et al. Remifentanil preconditioning protects the small intestine against ischemia\/reperfusion injury via intestinal delta- and mu-opioid receptors. Surgery. 2016;159(2):548-559. doi:10.1016\/j.surg.2015.07.028","DOI":"10.1016\/j.surg.2015.07.028"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Cho SS, Rudloff I, Berger PJ, et al. Remifentanil ameliorates intestinal ischemia-reperfusion injury. BMC Gastroenterol. 2013;13:69. doi:10.1186\/1471-230X-13-69","DOI":"10.1186\/1471-230X-13-69"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Liu C, Ding R, Huang W, Miao L, Li J, Li Y. Sevoflurane protects against intestinal ischemia-reperfusion injury by activating peroxisome proliferator-activated receptor gamma\/nuclear factor-kappaB pathway in rats. Pharmacology. 2020;105(3-4):231-242. doi:10.1159\/000503727","DOI":"10.1159\/000503727"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Liu C, Shen Z, Liu Y, et al. Sevoflurane protects against intestinal ischemia-reperfusion injury partly by phosphatidylinositol 3 kinases\/Akt pathway in rats. Surgery. 2015;157(5):924-933. doi:10.1016\/j.surg.2014.12.013","DOI":"10.1016\/j.surg.2014.12.013"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T07:25:10Z","timestamp":1705303510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/archive\/2023\/21\/12\/0\/992\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2020.0385","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}